hematoporphyrin derivative

hematoporphyrin derivative

Oncology An agent used in photodynamic therapy that is absorbed by tumor cells which is activated when exposed to light, killing tumor cells. See Photodynamic therapy.
References in periodicals archive ?
The role of lipid peroxidation and protein degradation in the photodestruction of Ehrlich ascites carcinoma cells sensitized by hematoporphyrin derivative.
Hydrogen peroxide, superoxide, and hydroxyl radicals are involved in the phototoxic action of hematoporphyrin derivative against tumor cells.
Hydrogen peroxide and hydroxyl free radical production by hematoporphyrin derivative, ascorbate and light.
Photodynamic generation of hydroxyl radicals by hematoporphyrin derivative and light.
Hyperthermal effects in phototherapy with hematoporphyrin derivative sensitization.
This dye, known initially as hematoporphyrin derivative (Hpd) and in purified form as Photofrin II, has been used to treat about 5,000 patients worldwide for many kinds of solid tumors, including those of the skin, lung, bladder, eye, head, neck and esophagus.
Effects of light exposure on the uptake and destruction of hematoporphyrin derivative in Ehrlich carcinoma cell suspension.
Quantum yields of singlet oxygen production by monomeric and aggregated forms of hematoporphyrin derivative.
Photooxidation of hematoporphyrin derivative bovine serum albumin complex.
Superoxide, hydrogen peroxide and singlet oxygen in hematoporphyrin derivative cysteine, -NADH and -light systems.